Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Manejo perioperatorio de feocromocitoma y paraganglioma

  • Magdalena Fermandois*
  • , Jaime Altamirano
  • , Felipe Rojas
  • , Cristóbal Román
  • , Iván Pinto
  • *Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

2 Citas (Scopus)

Resumen

Pheochromocytomas and paragangliomas are rare neuroendocrine tumors, characterized by a high morbidity rate due to catechola-mine excess. These high levels are independent of physiologic stressors. For the diagnosis, a biochemical workup is paramount. The most widely used are plasma-free metanephrines and urinary fractionated metanephrines. Imaging studies should be initiated once the biochemical diagnosis is established. Evaluation of the patient with pheochromocytomas and paragangliomas must be done taking into account the leading causes of perioperative morbidity and mortality. The two primary interventions that have reduced perioperative mortality are alpha-adrenergic blockade and intravascular volume normalization. Another significant advance has been the establishment of laparoscopic surgery as the gold standard for the surgical approach. No anesthetic technique has been found to be superior to another. Intraoperative hemodynamic instability has been correlated with poorer outcomes; thus one of the main intraoperative goals is maintaining hemodynamic stability. Lower morbidity and almost zero mortality rates due to preoperative and intraoperative management improvements have led to a focus on the immediate and long-term postoperative care. Anual lifelong follow-up is recommended to detect recurrent disease.

Título traducido de la contribuciónPerioperative management of paragangliomas and pheochromocytomas
Idioma originalEspañol
Número de artículoe7830
PublicaciónMedwave
Volumen20
N.º2
DOI
EstadoPublicada - mar. 2020

Nota bibliográfica

Publisher Copyright:
© 2020, Medwave Estudios Ltda. All rights reserved.

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Manejo perioperatorio de feocromocitoma y paraganglioma'. En conjunto forman una huella única.

Citar esto